Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii. - Wikidata - wikimedia - TriplyDB

Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii.

Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii.

http://www.wikidata.org/entity/Q40206223

about

NK cells in mucosal defense against infection Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain.The CD8 T-cell road to immunotherapy of toxoplasmosis.Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite.The immunology of parasite infections in immunocompromised hosts.CD8 T Cells and Toxoplasma gondii: A New Paradigm The Diverse Role of NK Cells in Immunity to Toxoplasma gondii Infection Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections.The survival of memory CD8 T cells that is mediated by IL-15 correlates with sustained protection against malaria.Long-term immunity to lethal acute or chronic type II Toxoplasma gondii infection is effectively induced in genetically susceptible C57BL/6 mice by immunization with an attenuated type I vaccine strain.CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection.Flt3 Ligand Is Essential for Survival and Protective Immune Responses during Toxoplasmosis Gamma interferon suppresses erythropoiesis via interleukin-15.The Four-Way Stop Sign: Viruses, 12-Lipoxygenase, Islets, and Natural Killer Cells in Type 1 Diabetes Progression

P2860

Q26861168-01EF58C6-8A45-4EA0-B9D9-555FABD12276 Q30354096-6FF1ABA4-057F-4DA0-B265-CBA1B84BEB36 Q33732215-BC6E088D-0852-42ED-A492-7221D9BAA927 Q34597905-23B33C43-3DCC-41AF-AF80-DF9260D3000C Q35029729-2DFCC45A-1395-4AED-8EC6-A038A7B44B53 Q35038836-CBD6C3DE-9DB3-4F3E-B60D-33307403BE04 Q35935856-613C8793-13D7-4B54-93A0-8D5CCACB347A Q36426058-C606B3F7-1F05-4917-9477-11BC60F64E5F Q36823985-9E5D7F3F-AD1A-40F4-A131-35BB326B311F Q37451015-822F00B1-2E28-4550-B370-BAB3FF0C567A Q38461484-217193A5-7214-426A-BE70-0F90A94EC62A Q40991779-ECD94E0E-119F-4D30-8C7A-446E790CECAB Q41842533-F0A9C26C-8C22-4C5C-B6FA-43A7578EEFEC Q41921221-93703729-3BFC-4C3D-A473-E3750DE15A22

P2860

Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii.

http://www.wikidata.org/entity/Q40206223

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii.

@en

type

label

Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii.

@en

prefLabel

Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii.

@en

P1433

Q40206223-94718B5B-7931-43DD-B887-B2E693359C6A

P1476

Q40206223-3D320A6F-7FDE-47A2-A390-72086CF01644

P2093

Q40206223-9ED93E0C-305B-4F64-9058-433D2FBA9BD3

Q40206223-BEDA8141-F4CD-432F-9BC2-E5B8196C2382

Q40206223-BF5E0819-DDF7-4F31-BF99-0947847BFDE1

P2860

Q40206223-09B61AFB-2E78-4DE5-8967-F64C6A1D5FA3

Q40206223-0DBD5ECD-5B02-4726-9ECE-CAC968B25E7B

Q40206223-101AB4D6-F941-4687-A8B2-F3A66227574F

Q40206223-5033E0E2-F65B-4D18-9134-4CDA7703EA87

Q40206223-527537D4-9A6A-4359-B413-BD34947836AF

Q40206223-5DCD9C87-9A03-42B4-BB98-D0E94F6074C3

Q40206223-61B1F8AD-2AD0-4C5A-B176-FFCED8D21F9B

Q40206223-682CE90B-59F1-4EB8-8EC5-DB818757A995

Q40206223-72E4468C-C89F-4E6E-98B6-438DDE6BAC5D

Q40206223-85C93F42-2E7E-4D2A-9750-F7EB7B8CAD4D

P304

Q40206223-B23FB29B-8529-4A36-B0E3-AE4BF4BD802A

P31

Q40206223-A8586604-4137-4DCE-86B4-13E1481D5832

P356

Q40206223-944DDD08-04D6-4253-8859-F7F7D968EB13

P407

Q40206223-6698F81F-ECE5-484A-8E96-4E6C0D183A4B

P433

Q40206223-13487545-0657-4FCE-A15D-35E3358C088D

P478

Q40206223-D09E1FB7-EBA0-4880-A6C7-A2228FCEB9E6

P577

Q40206223-4363EB7D-C222-4284-8E9D-9BE72C87696D

P698

Q40206223-018524C6-6C30-4419-9B2C-AEF661244950

P921

Q40206223-49A44087-F5CE-4293-9944-790B655BA85B

P932

Q40206223-52DAC86F-64BB-42C9-BEC2-1E6EC7376D9A

P356

IAI.72.11.6729-6732.2004

P1433

Infection and Immunity

P1476

Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii.

@en

P2093

Christopher A Hunter

http://www.w3.org/2001/XMLSchema#string

Eric N Villegas

http://www.w3.org/2001/XMLSchema#string

Linda A Lieberman

http://www.w3.org/2001/XMLSchema#string

P2860

Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15

Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells

Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response

IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells

IL-21 induces the functional maturation of murine NK cells

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

Interleukin 15: biology and relevance to human disease.

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells

Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.

P304

6729-6732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.72.11.6729-6732.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15501812

http://www.w3.org/2001/XMLSchema#string

P921

Toxoplasma gondii

P932

523054

http://www.w3.org/2001/XMLSchema#string